Immunotherapy

Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients.

Dyskinesias in Parkinson’s Disease: Promising New Treatment Approach

A CAR-T cell (orange) has attacks a cancer cell (green), which is starting to contract.

How long might CAR-T cell therapy work?

Immunotherapy IL-15 agonist

First-in-class IL-15 superagonist wins FDA approval